Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1304 of 5804
-
New balloon zaps heart rhythm problem in first human test
Disease control Recruiting nowThis is a prospective, single-arm First-in-Human study to demonstrate the safety and effectiveness of the CardioFocus OptiShot Pulsed Field Ablation System for catheter ablation of atrial fibrillation (AF). Patients with symptomatic paroxysmal (short-duration) AF who have not had…
Phase: NA • Sponsor: CardioFocus • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can cutting back on drinking help stop HIV? malawi study aims to find out.
Prevention Recruiting nowPurpose: To evaluate short-term efficacy and implementation of Treat4All, an alcohol reduction evidence-based intervention, for decreasing heavy drinking and optimizing HIV outcomes (viral suppression among People with HIV (PWH); Pre-exposure prophylaxis (PrEP) use among those at…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Acupuncture may help black women avoid debilitating joint pain during breast cancer treatment
Symptom relief Recruiting nowThis clinical trial evaluates if in-person acupuncture or virtual acupressure therapy prevents aromatase inhibitor-associated joint pain in Non-Hispanic Black postmenopausal women with stage I-III (early-stage) hormone receptor positive (HR+) breast cancer. Aromatase inhibitors (…
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can four therapy sessions curb suicide risk in BPD? new trial aims to find out
Symptom relief ENROLLING_BY_INVITATIONWhen in crisis, people with borderline personality disorder (BPD) frequently seek care in emergency departments (EDs) often presenting with suicide and self-harm behaviour. There is no established evidence-based brief treatment for patients with BPD in ED settings, however a 4-se…
Phase: NA • Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New mesh aims to stop painful breast implant scarring
Disease control Recruiting nowProspective, randomized, controlled study to assess the safety and effectiveness of GalaFLEX LITE™ Scaffold in revision surgery for reduction of capsular contracture recurrence and/or malposition in implant-based breast augmentation patients versus patients undergoing conventiona…
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Faster MRI could replace CT scans for liver cancer survivors
Diagnosis Recruiting nowHepatocellular carcinoma (HCC) often has a poor prognosis after curative treatment due to frequent recurrence. Post-surgery, 60-70% of HCC patients experience recurrence, rising to 80% after ablation therapy. This is partly because underlying cirrhosis or chronic liver disease re…
Phase: NA • Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Second Time's the charm? new study tests replacing heart valves again without surgery
Disease control Recruiting nowTranscatheter aortic valve implantation (TAVI) is a key-hole technique to replace an aortic heart valve that is narrowed and/or leaking. Although TAVI is a safe and effective treatment for a faulty aortic heart valve, the new TAVI valve will not last forever. Because it is a 'tis…
Sponsor: The Leeds Teaching Hospitals NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for advanced cancer patients as experimental drug enters human testing.
Disease control Recruiting nowThis is an open-label, nonrandomized, multicenter, Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of MK-6204 as monotherapy in participants with advanced solid tumors.
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New group care model aims to boost HIV prevention in sex workers
Prevention OngoingUsing a participatory implementation science framework, I will test whether an adapted and community empowered group healthcare model, Centering PrEP+, is a feasible and acceptable health system intervention to improve the health of sex workers and their clients by increasing PrE…
Phase: EARLY_PHASE1 • Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Scientists probe why tezepelumab doesn't stop all asthma attacks
Knowledge-focused CompletedTezepelumab is a treatment that is approved by NICE (National Institute for Health and Care Excellence, https://www.nice.org.uk/) for patients with severe asthma, that remains poorly controlled despite high dose inhaled glucocorticosteroid medication. The goal of this observatio…
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
New DNA reader aims to solve mystery of undiagnosed ataxia cases
Knowledge-focused Recruiting nowCerebellar ataxias are a group of rare neurological disorders that are clinically and genetically heterogeneous, with several hundred genes and diseases known to date. Over the last decade, their diagnosis has been revolutionised by the development of high-throughput sequencing t…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New hope for ulcerative colitis: experimental drug enters human trials
Disease control Recruiting nowAdults between 18 and 80 years of age with ulcerative colitis can participate in this study. This is a study for people for whom previous treatment was not successful or who stopped previous treatment. The purpose of this study is to find out whether BI 3032950 helps people with …
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New eye injection aims to slow blindness in rare genetic disease
Disease control OngoingThe purpose of this Phase 2b study is to evaluate the safety and tolerability of ultevursen administered via intravitreal injection (IVT) in subjects with Retinitis Pigmentosa (RP) due to mutations in exon 13 of the USH2A gene. This is a multicenter Double-masked, Randomized, Sha…
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Experimental antibody trio takes on Hard-to-Treat melanoma
Disease control OngoingWhy the research is needed: Researchers are looking for a better way to treat melanoma that has spread or cannot be removed surgically. Melanoma is a type of skin cancer that starts in melanocytes, the cells that make the pigment that gives skin its color. In people with cancer, …
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug shows promise against rare liver infection
Disease control OngoingThe goal of this clinical trial is to evaluate the efficacy and safety of L47 in the treatment of chronic hepatitis D. Patients with compensated CHD who satisfy the eligibility criteria are stratified by the presence or absence of liver cirrhosis and randomized into three groups …
Phase: PHASE2 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
App aims to prevent pregnancy-related deaths in minority women
Knowledge-focused CompletedPregnancy-related death is a growing public health issues, which are of particular concern to minority groups, including African-Americans and Spanish-speaking Latinas. Our proposal aims to improve a patient's ability to detect warning signs of pregnancy related death and seek me…
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Blood test may let some lymphoma patients skip late chemo rounds
Knowledge-focused Recruiting nowThe purpose of this study is to 1) determine whether it is feasible to measure circulating tumor DNA (ctDNA) in real-time during standard treatment for newly diagnosed diffuse large B-cell lymphoma (DLBCL), and 2) evaluate the outcomes of participants with undetectable ctDNA in t…
Phase: NA • Sponsor: Hua-Jay J Cherng, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo could tame autoimmune hepatitis and cut steroid use
Disease control Recruiting nowBackground: Autoimmune hepatitis (AIH) is a rare chronic and lifelong liver disease. Untreated, disease progresses to end-stage cirrhosis and the focus of therapy is with immunosuppression. Current therapies are limited, not targeted, and associated with side effects that patient…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Less may be more: smaller surgery for melanoma tested in 1,000-Patient trial
Disease control Recruiting nowThis clinical trial compares the effect of a narrow surgical excision (removal) to a wide excision for the treatment of adults with invasive cutaneous melanoma. Currently the standard of care is to take wide margins (boarder of healthy tissue surrounding the melanoma) when removi…
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Virtual reality could make depression therapy more immersive and effective
Disease control CompletedStudy Overview This study aims to evaluate the effectiveness of a newly developed Virtual Reality (VR) behavioral activation software program for individuals experiencing symptoms of depression. Behavioral activation is a well-established psychological approach that helps individ…
Phase: NA • Sponsor: KTO Karatay University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC